Kun Zhang
Direttore/Membro del Consiglio presso SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Patrimonio netto: 3 M $ in data 30/04/2024
Posizioni attive di Kun Zhang
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Direttore/Membro del Consiglio | 20/04/2018 | - |
Corporate Officer/Principal | 20/04/2018 | - |
Storia della carriera di Kun Zhang
Precedenti posizioni note di Kun Zhang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/11/2014 | 01/10/2020 |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Vendite & Marketing | 01/05/2009 | 01/01/2011 |
MICROPORT SCIENTIFIC CORPORATION | Vendite & Marketing | 01/05/2002 | 01/03/2004 |
Formazione di Kun Zhang
Academy of Armored Forces Engineering | Undergraduate Degree |
City University of Hong Kong | Masters Business Admin |
Statistiche
Distribuzione geografica
Cina | 5 |
Isole Cayman | 2 |
Hong Kong | 2 |
Posizioni
Sales & Marketing | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
Aziende private | 1 |
---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Kun Zhang
- Esperienza